Gene · 9582
Papers1,875
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,875
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis. | Int J Mol Sci | 2023 | 38069117 | PubTator, text mining | PubMed |
| Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis. | Cancers (Basel) | 2023 | 38067328 | PubTator, text mining | PubMed |
| Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer. | PLoS Genet | 2023 | 38033156 | PubTator, text mining | PubMed |
| Engineered deaminases as a key component of DNA and RNA editing tools. | Mol Ther Nucleic Acids | 2023 | 38028200 | PubTator, text mining | PubMed |
| Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38022729 | PubTator, text mining | PubMed |
| APOBEC3A suppresses cervical cancer via apoptosis. | J Cancer | 2023 | 38021159 | PubTator, text mining | PubMed |
| Acute expression of human APOBEC3B in mice results in RNA editing and lethality. | Genome Biol | 2023 | 38001542 | PubTator, text mining | PubMed |
| [SWI/SNF Complex Gene Mutations Promote the Liver Metastasis of Non-small Cell Lung Cancer Cells in NSI Mice]. | Zhongguo Fei Ai Za Zhi | 2023 | 37989338 | PubTator, text mining | PubMed |
| Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis. | Cancer Med | 2023 | 37974533 | PubTator, text mining | PubMed |
| Prognostic value of APOBEC3A in patients with cervical squamous cell carcinoma in a major urban center in China: a retrospective study. | Transl Cancer Res | 2023 | 37969401 | PubTator, text mining | PubMed |
| The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. | bioRxiv | 2023 | 37961409 | PubTator, text mining | PubMed |
| RNA Editing in Cancer Progression. | Cancers (Basel) | 2023 | 37958449 | PubTator, text mining | PubMed |
| Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma. | Heliyon | 2023 | 37954334 | PubTator, text mining | PubMed |
| Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes. | Sci Adv | 2023 | 37922356 | PubTator, text mining | PubMed |
| Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma. | Sci Rep | 2023 | 37903974 | PubTator, text mining | PubMed |
| Identification and Analysis of a Four-Gene Set for Diagnosing SFTS Virus Infection Based on Machine Learning Methods and Its Association with Immune Cell Infiltration. | Viruses | 2023 | 37896902 | PubTator, text mining | PubMed |
| Differential RNA editing landscapes in host cell versus the SARS-CoV-2 genome. | iScience | 2023 | 37876814 | PubTator, text mining | PubMed |
| SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions. | Nat Commun | 2023 | 37872175 | PubTator, text mining | PubMed |
| Molecular genetic aberrations in the pathogenesis of multiple myeloma. | Asian Biomed (Res Rev News) | 2023 | 37860676 | PubTator, text mining | PubMed |
| ATM, KAP1 and the Epstein-Barr virus polymerase processivity factor direct traffic at the intersection of transcription and replication. | Nucleic Acids Res | 2023 | 37852757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9582/papers?page=8